Grace A. Ilevbare

1.4k citations
10 papers · 1.3k indexed · h-index 10

Grace A. Ilevbare

10 papers receiving 1.2k citations

Peers

Grace A. Ilevbare
Comparison fields: 5 of 81
  • Pharmaceutical Science 952
  • Materials Chemistry 720
  • Spectroscopy 240
  • Analytical Chemistry 124
  • Biomaterials 103
Replace Devalina Law with:
Devalina Law United States
Sharad B. Murdande United States
Shrawan Baghel Ireland
Shweta A. Raina United States
Keisuke Ueda Japan
Sandrien Janssens Belgium
Hee Jun Park South Korea
Chris Brough United States
Alfred C. F. Rumondor United States
Manabu Nakatani Japan
Grace A. Ilevbare relative to Devalina Law United States Devalina Law's profile →
Citations per field
00.5×1.5×2.2×
Devalina Law · 1×
Citations per year

Countries citing papers authored by Grace A. Ilevbare

Since Specialization
Citations

This map shows the geographic impact of Grace A. Ilevbare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace A. Ilevbare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace A. Ilevbare more than expected).

Fields of papers citing papers by Grace A. Ilevbare

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace A. Ilevbare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace A. Ilevbare. The network helps show where Grace A. Ilevbare may publish in the future.

Co-authorship network

The 11 scholars most cited alongside Grace A. Ilevbare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Grace A. Ilevbare Line = papers co-authored together Grace A. Ilevbare links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 201392
2 201381
3 2013305
4 201351
5 2012121
6 201251
7 201267
8 2012212
9 201289
10 2012187

About Grace A. Ilevbare

Grace A. Ilevbare is a scholar working on Pharmaceutical Science, Spectroscopy and Materials Chemistry, having authored 10 papers that have together received 1.3k indexed citations. Recurring topics across this work include Crystallization and Solubility Studies (7 papers), Drug Solubulity and Delivery Systems (6 papers), Analytical Chemistry and Chromatography (5 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), HIV/AIDS drug development and treatment (2 papers), Protein purification and stability (2 papers), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Pharmaceutical Science (952 citations), Materials Chemistry (720 citations) and Spectroscopy (240 citations). Grace A. Ilevbare has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Lynne S. Taylor, Kevin J. Edgar, Haoyu Liu, Karl Box, Manuel Sánchez-Félix, Bernard Van Eerdenbrugh, Yi‐Ling Hsieh, Benjamin P. Cherniawski, Raquel Mejia‐Ariza and Nammalwar Sriranganathan. Their work appears in journals such as Carbohydrate Polymers, Pharmaceutical Research and Crystal Growth & Design.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026